Related by context. Frequent words. (Click for all words.) 60 Refractory 56 cutaneous T cell 55 rituximab 55 refractories 55 NSCLC 54 hormone refractory prostate cancer 54 follicular lymphoma 54 fludarabine 53 docetaxel 53 cytarabine 53 retreatment 53 monotherapy 53 chronic lymphocytic leukemia CLL 53 relapsed 52 chemotherapy regimens 51 carboplatin 51 HRPC 51 CTCL 51 soft tissue sarcomas 51 ZEVALIN 51 solid tumors 51 dasatinib 51 myelofibrosis 51 evaluable 50 imatinib 50 chronic myeloid leukemia CML 50 temozolomide 50 Rituximab 50 oxaliplatin 50 hematologic malignancies 50 pemetrexed 49 pixantrone 49 metastatic colorectal cancer 49 soft tissue sarcoma 49 hematologic 49 acute myeloid leukemia AML 49 eculizumab 49 ocular hypertension 49 evaluable patients 48 invasive bladder 48 metastatic 48 hematological malignancies 48 mitoxantrone 48 advanced NSCLC 48 hematological 48 gefitinib 48 DMARDs 48 5 FU 48 randomized Phase 48 autologous stem cell 48 AML 48 MGCD# [002] 48 RRMS 48 sunitinib 48 bone metastases 48 blinatumomab 48 vandetanib 47 CLL 47 relapsing remitting multiple sclerosis 47 Phase 2b clinical 47 critical limb ischemia 47 IMGN# 47 adjuvant therapy 47 renal cell carcinoma 47 benign prostatic hyperplasia 47 epratuzumab 47 gemcitabine 47 hepatocellular carcinoma 47 hepatocellular carcinoma HCC 47 mCRC 47 myelodysplastic syndromes 47 tamibarotene 47 Zevalin 47 taxane 47 metastatic melanoma 47 cutaneous 47 Marqibo 47 infliximab 47 pivotal Phase 46 anthracyclines 46 cell malignancies 46 pathologic 46 REVLIMID 46 FOLFOX 46 Atiprimod 46 sintering 46 fluorouracil 46 anti TNF 46 adjunctive treatment 46 erlotinib 46 plus ribavirin 46 irinotecan 46 relapsing remitting MS 46 prophylaxis 46 dose escalation 46 sinter 46 oral mucositis 46 Alpharadin 46 Phase 2b study 46 Phase 2a trial 46 5 fluorouracil